Ultrasound can dynamically evaluate the efficacy of GnRHa in the treatment of central precocious puberty. Pelvic ultrasound has significant predictive value in evaluating the efficacy of GnRHa therapy at the early diagnosis of central precocious puberty.
Chu et al. (Tue,) studied this question.